HCL2025 Researcher Profile: Dr. David Ritchie, University of Melbourne

The HCL2025 research initiative is a collaboration of the Hairy Cell Leukemia Foundation and the Leukemia & Lymphoma Society to identify new and better therapies for hairy cell leukemia and improve patient outcomes. Our HCL2025 Profile Series is highlighting the outstanding investigators whose discoveries will pave the way for new treatment options in HCL.

Today, we're highlighting Dr. David Ritchie from the University of Melbourne. His clinical research focuses on immunology and immunotherapy in blood cancers, such as HCL.

Dr. Ritchie has published over 200 peer-reviewed articles and has been awarded funding from the HCLF and LLS to understand the prognostic relationship between the immunologic and genomic signatures in Hairy Cell Leukemia.

In his research, Dr. Ritchie aims to define the genomic and immune landscape of HCL as it relates to diagnosis, therapeutic decisions, and disease monitoring in patients. An overview is linked here: https://medicine.unimelb.edu.au/research-groups/medicine-research/royal-melbourne-hospital/acrf-translational-research-laboratory/Integrative-genomics-and-immunobiology-in-Hairy-Cell-Leukaemia

The University of Melbourne, located in Melbourne, is a leading research institution and Australia's second-oldest university. It has frequently been ranked among the top 40 universities in the world.

Check out Dr. Ritchie's University of Melbourne profile here: https://findanexpert.unimelb.edu.au/profile/192881-david-ritchie

For summaries of research being carried out by our incredible cohort of HCL2025 grantees across the globe, visit our website here: https://www.hairycellleukemia.org/hcl2025